Search the web
Sign In
New User? Sign Up
dysferlin · Dysferlin Deficiency
? Already a member? Sign in to Yahoo!

Yahoo! Groups Tips

Did you know...
Show off your group to the world. Share a photo of your group with us.

Best of Y! Groups

   Check them out and nominate your group.
Having problems with message search? Fill out this form to ensure your group is one of the first to be migrated to the new message search system.

Messages

  Messages Help
Advanced
new dysferlin research   Message List  
Reply | Forward Message #79 of 592 |
Re: [dysferlin] Potential treatment in dysferlin research


This image is a complement to my last letter 18 july on RNA-mediated repair of
gene instruction.
sophareth

sophareth <sophareth@...> a écrit : Dear members,

Since the dysferlin gene is known, why antisense/sense paradigm has
not been used more intensively in clinical research? Ce paradigm is
based on the RNA interference mechanism discovered some 3-4 y ago.

Sophareth Camsonne




--- In dysferlin@y..., Daniel MacArthur <danielm@c...> wrote:
> Brad:
> > There are 8 presentations and one discussion workshop on
dysferlin in
> > the program for the upcoming Internatioal Congress on
Neuromuscular
> > Diseases in July 2002. (one of them is co-authored by group
member
> > Daniel MacArthur).
>
> Daniel:
> Thanks for the mention, Brad! While I won't be able to attend the
> Congress myself, several people from my lab will be paying close
> attention to the presentations and posters on dysferlinopathies -
in
> particular the presenting author of the dysferlin/calpain poster,
> Harriet Lo, who started her PhD this year investigating the
diagnosis
> and pathogenesis of dysferlin- and calpain-related muscular
> dystrophies.
>
> While my research has moved away from dysferlin (I'm now working on
> another muscle protein, alpha-actinin-3) I'm still paying close
> attention to the field of dysferlinopathy - firstly because I think
> that understanding dysferlin will greatly illuminate the processes
> behind muscular dystrophy in general, and secondly because it's an
> extremely interesting and fast-moving field.
>
> Brad:
> > I've listed them on the dysferlin website:
> >
> > http://www.dysferlin.org/research.htm#mws2001
>
> Daniel:
> Just a quick question, Brad - I haven't been able to link to your
> website for several weeks, and I was wondering if you were having
> any problems with your server, or if it was more likely to be a web
> problem at my end?
>
> Brad:
> > Although this research might not have any immediate implications
for
> > patients, the number of research groups giving presentations on
this
> > topic is, in my view, a very positive sign.
>
> Daniel:
> I couldn't agree more!
>
>
> Daniel.
>
> Daniel MacArthur
> Institute for Neuromuscular Research
> Neurogenetics Unit
> Clinical Sciences
> The Children's Hospital at Westmead
> Locked Bag 4001, Westmead
> Sydney, NSW 2145
> AUSTRALIA
> Phone: 61-2-9845-3101
> Fax: 61-2-9845-3078
> danielm@c...
>
>
>
**********************************************************************
> This email and any files transmitted with it are confidential and
> intended solely for the use of the individual or entity to whom they
> are addressed. If you are not the intended recipient, please
> delete it and notify the sender.
>
> Views expressed in this message and any attachments are those
> of the individual sender, and are not necessarily the views of the
> Childrens Hospital at Westmead
>
> This footnote also confirms that this email message has been
> virus scanned and although no computer viruses were detected,
> the Childrens Hospital at Westmead accepts no liability for any
> consequential damage resulting from email containing computer
> viruses.
>
**********************************************************************
>
>
>
> [Non-text portions of this message have been removed]



Yahoo! Groups SponsorADVERTISEMENT

To unsubscribe from this group, send an email to:
dysferlin-unsubscribe@yahoogroups.com



Your use of Yahoo! Groups is subject to the Yahoo! Terms of Service.



---------------------------------
Yahoo! Mail -- Une adresse @yahoo.fr gratuite et en français !


[Non-text portions of this message have been removed]





Fri Jul 19, 2002 7:05 am

sophareth
Offline Offline
Send Email Send Email

Forward
Message #79 of 592 |
Expand Messages Author Sort by Date

There are 8 presentations and one discussion workshop on dysferlin in the program for the upcoming Internatioal Congress on Neuromuscular Diseases in July...
baw1064
Offline Send Email
May 31, 2002
2:14 am

... Daniel: Thanks for the mention, Brad! While I won't be able to attend the Congress myself, several people from my lab will be paying close attention to the...
Daniel MacArthur
mesk125
Offline Send Email
Jun 4, 2002
11:21 pm

Dear members, Since the dysferlin gene is known, why antisense/sense paradigm has not been used more intensively in clinical research? Ce paradigm is based on...
sophareth
Offline Send Email
Jul 17, 2002
11:35 pm

... Dear Sophareth, Thanks for answering and furthering my questions in a so unexpected way, though. I was thinking that antisense/ sense RNA paradigm's...
natalisan
Offline Send Email
Jul 21, 2002
4:59 pm

Nat, The big big problem is to define precisely the molecular etiology of diverse forms of dysferlinopathies and their numberless regulation networks. ...
sophareth Camsonne
sophareth
Offline Send Email
Jul 28, 2002
9:38 pm

Hi everyone! Nice to be back! Thank you Brad for filling in my last message for me:) Concerning RNA interference/ repairing. An intro to this new kind of...
natalisan
Offline Send Email
Sep 24, 2002
1:31 am

Dear Dyferliners, Dysferlinopathies seem to be, at least for instant, a recessive disorder. Such as the antisense/sense paradigm (suppression of pathological...
sophareth
Offline Send Email
Jul 21, 2002
4:59 pm

This image is a complement to my last letter 18 july on RNA-mediated repair of gene instruction. sophareth sophareth <sophareth@...> a écrit : Dear...
sophareth Camsonne
sophareth
Offline Send Email
Jul 21, 2002
4:59 pm
Advanced

Copyright © 2009 Yahoo! Inc. All rights reserved.
Privacy Policy - Terms of Service - Guidelines - Help